跳至主要内容
临床试验/JPRN-jRCT1080225055
JPRN-jRCT1080225055招募中Unknown

Adverse Drug Reaction Frequency Investigation of TSUMURA Hochuekkito Extract Granules for Ethical Use

Tsumura & Co.0 个研究点目标入组 3,300 人开始时间: 2020年2月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
Tsumura & Co.
入组人数
3,300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • TJ-41 is indicated for the following symptoms/conditions of patients having delicate constitution, reduced digestive func-tions, and severe fatigability of limbs:
  • Summer emaciation, reinforcement of physical strength after illness, tuberculosis, anorexia, gastroptosis, cold, hemorrhoid, anal prolapse, uterine prolapse, impotence, hemiplegia, and hyperhidrosis.
  • The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals.
  • Patients who have never taken TJ-41 in the past, or have been 6 months or more since the last dose.

排除标准

  • 未提供

研究者

发起方
Tsumura & Co.

相似试验